Insider Transactions

Date	Name	Title	Type	Shares Traded	Price Range
Nov 26, 2008	Uveges, George	Director	Buy	2,500	1.95 - 1.96
Aug 22, 2007	hso limited partnership	Beneficial Owner (10% or more)	Buy	2,565	4.64
Aug 1, 2007	hso limited partnership	Beneficial Owner (10% or more)	Buy	2,578	4.94
Aug 1, 2007	skystone advisors llc	Beneficial Owner (10% or more)	Buy	2,585	4.94
Mar 2, 2009	Green, David	Officer	Automatic Buy	2,587	2.49
Jul 31, 2007	skystone advisors llc	Beneficial Owner (10% or more)	Buy	2,606	4.97
Aug 31, 2007	skystone advisors llc	Beneficial Owner (10% or more)	Buy	2,617	4.60
Apr 26, 2011	Green, David	Officer	Automatic Sell	2,944	5.97
Aug 27, 2007	hso limited partnership	Beneficial Owner (10% or more)	Buy	3,015	4.68
Dec 2, 2008	Green, David	Officer	Automatic Buy	3,200	2.00
Aug 21, 2007	skystone advisors llc	Beneficial Owner (10% or more)	Buy	3,387	4.54
Aug 27, 2007	skystone advisors llc	Beneficial Owner (10% or more)	Buy	3,400	4.68
Aug 22, 2007	skystone advisors llc	Beneficial Owner (10% or more)	Buy	3,761	4.64
Dec 11, 2007	Uveges, George	Director	Buy	4,000	4.10 - 4.15
Dec 31, 2007	skystone advisors llc	Beneficial Owner (10% or more)	Buy	4,362	4.51
Feb 26, 2009	Green, David	Officer	Automatic Buy	4,789	2.49
Nov 19, 2007	hso limited partnership	Beneficial Owner (10% or more)	Buy	5,043	3.74
Aug 3, 2007	hso limited partnership	Beneficial Owner (10% or more)	Buy	5,375	4.93
Sep 16, 2009	Lewis, Earl R.	Director	Buy	5,534	3.75
Nov 20, 2007	hso limited partnership	Beneficial Owner (10% or more)	Buy	5,617	3.87
Showing 21-40 of 123 transactions Page: 1 2 3 4 5 6 7  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.